Denovo Biopharma Email Formats

Biotechnology Research • San Diego, California, United States • 21-50 Employees

Denovo Biopharma Email Formats

Denovo Biopharma uses 2 email formats. The most common is {first initial}{last name} (e.g., jdoe@denovobiopharma.com), used 86.7% of the time.

Format	Example	Percentage
{first initial}{last name}	jdoe@denovobiopharma.com	86.7%
{first name}{last name}	johndoe@denovobiopharma.com	13.3%

Key Contacts at Denovo Biopharma

Liz Christiansen

Director, Regulatory Operations, Rims/Dms Lead

Julie Doostzadeh

Executive Director Of Clinical Operations

Sina Burrell

Executive Director, Head Of Quality Assurance

Company overview

Headquarters	10240 Science Center Dr, San Diego, California 92121, US
Website	denovobiopharma.com
SIC	873
Keywords	Drug Development, Depression, Oncology, CNS, Clinical Trial, Biomarker, Antidepressant
Founded	2012
Employees	21-50
Socials

About Denovo Biopharma

A Novel Biomarker Discovery Solution for Personalized Drug Development Denovo Biopharma is a private San Diego based biotech company providing a novel biomarker solution to personalize drug development. The core technology of the company is its industry's first platform and algorithm to perform de novo genomic biomarker discovery retrospectively using archived clinical samples. This technology is especially useful for late stage clinical drugs that have completed trials with unsatisfactory efficacy or side effects. By identifying biomarkers correlated to patients' responsiveness to drug candidates retrospectively, our technology enables biotech and pharmaceutical companies to design new clinical trials in targeted patient population to achieve higher efficacy and/or less adverse effects. Our platform can be broadly applied to biomarker discovery in most therapeutic areas, such as oncology and neurological diseases. Denovo’s lead asset, liafensine, a first-in-class antidepressant in Phase 3 development. Liafensine has shown robust efficacy in ANK3-positive patients with treatment-resistant depression (TRD) in a pivotal study in addition to an excellent safety profile based on data from nearly 1500 individuals exposed to the drug. This non-psychedelic oral pill represents the first precision medicine in psychiatry with the potential to shift the treatment paradigm for TRD, a highly unmet medical need. We are seeking funding to complete one more pivotal study to file NDA.

Employees by Management Level

Total employees: 21-50

Seniority

Employees

Entry

C-Suite

Director

Employees by Department

Denovo Biopharma has 11 employees across 6 departments.

Departments

Number of employees

Funding Data

Explore Denovo Biopharma's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2021-01-10	7	$45,800,000
2024-05-30	9	$11,800,000

Funding Insights

$57,600,000

Total funding amount

$11,800,000

Most recent funding amount

Number of funding rounds

Denovo Biopharma Tech Stack

Discover the technologies and tools that power Denovo Biopharma's digital infrastructure, from frameworks to analytics platforms.

Nginx

Reverse proxies

HSTS

Security

Microsoft 365

Frequently asked questions

Denovo Biopharma is located in San Diego, California, US.

Denovo Biopharma was founded in 2012, making it 14 years old. The company has established itself as a significant player in its industry over this time.

Denovo Biopharma has approximately 21-50 employees. The company continues to grow its workforce to support its business operations and expansion.

Denovo Biopharma has raised a total of $57,600,000 across 2 funding rounds. This investment has helped the company grow and expand its operations.